IDE-ALERTS Continued Access Study

NCT04316481 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
17
Enrollment
INDUSTRY
Sponsor class

Stopped FDA Approval was received for the Model AMSG3-E IMD and therefore commercial implants could be started. There was no longer any need to implant under the CAS. CAS patients were transitioned to commercial patients.

Conditions

Interventions

Sponsor

Angel Medical Systems